Change‐of‐function fibroblast growth factor receptor 3 mutations causing skeletal dysplasias
Journal of Cell Communication and Signaling · 2026-12 · 20 (4)
DOI: 10.1002/ccs3.70119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Communication and Signaling, online erschienen am 30.10.2026. Verfasst von Tanaya Roy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Engineering and Institute for NanoBioTechnology Johns Hopkins University Baltimore Maryland USA. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fibroblast growth factor receptor 3 (FGFR3) is a membrane protein that plays a critical role as a negative regulator in the growth and development of the skeletal system. Mutations in FGFR3 cause a range of skeletal dysplasias. The G380R mutation in FGFR3 causes achondroplasia (ACH), the most common form of human short‐limbed dwarfism, whereas the A391E mutation in FGFR3 causes Crouzon syndrome, a craniosynostosis characterized by premature fusion of sutures between the cranial bones, with acanthosis nigricans. Both mutations are considered “gain‐of‐function” and occur close to each other within the simple FGFR3 helix that spans the membrane. Yet, the two pathological phenotypes of ACH and Crouzon syndrome are distinctly different. Here, we show that FGFR3 engages in biased signaling. We further show that the G380R and A391E mutations do not simply amplify signaling but differentially reshape the FGFR3 signaling patterns. The data provide an explanation of the distinctly different phenotypes due to the two mutations and lead us to propose that the mutations are “change‐of‐function.”
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Materials Science and Engineering and Institute for NanoBioTechnology Johns Hopkins University Baltimore Maryland USA.
- Department of Biology Faculty of Medicine Masaryk University Brno Czechia.
- International Clinical Research Center St. Anne's University Hospital Brno Czechia.
- Institute of Animal Physiology and Genetics of the Czech Academy of Sciences Brno Czechia.
ORCID-Profile: Zuzana Feketova, Jiawei Liu, Pavel Krejci, Kalina Hristova
Zitieren
APA
Roy, T., Feketova, Z., Liu, J., Krejci, P., & Hristova, K. (2026). Change‐of‐function fibroblast growth factor receptor 3 mutations causing skeletal dysplasias. Journal of Cell Communication and Signaling, 20(4). https://doi.org/10.1002/ccs3.70119
Vancouver
Roy T, Feketova Z, Liu J, Krejci P, Hristova K. Change‐of‐function fibroblast growth factor receptor 3 mutations causing skeletal dysplasias. Journal of Cell Communication and Signaling. 2026;20(4). doi:10.1002/ccs3.70119
BibTeX
@article{Roy2026,
author = {Roy, Tanaya and Feketova, Zuzana and Liu, Jiawei and Krejci, Pavel and Hristova, Kalina},
title = {Change‐of‐function fibroblast growth factor receptor 3 mutations causing skeletal dysplasias},
journal = {Journal of Cell Communication and Signaling},
year = {2026},
volume = {20},
number = {4},
doi = {10.1002/ccs3.70119}
}
EUVIMED